Karyl Hobbs, PA
Medical · Winter Haven, FLNPI 1457696080
Payments from drug & device makers
Across 243 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$572
- AstraZeneca$536
- Exact Sciences$404
- Lilly USA, LLC$317
- Amgen$220
- Boehringer Ingelheim$178
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,52699%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $572 |
| AstraZeneca | 33 | $536 |
| Exact Sciences | 16 | $404 |
| Lilly USA, LLC | 18 | $317 |
| Amgen | 15 | $220 |
| Boehringer Ingelheim | 9 | $178 |
| GSK | 10 | $174 |
| AbbVie | 8 | $168 |
| Endo USA, Inc. | 6 | $158 |
| Amarin Pharma, Inc. | 8 | $146 |
| Johnson & Johnson(2 entities) | 7 | $144 |
| Merck | 8 | $141 |
| Pfizer | 6 | $138 |
| Sanofi-aventis U.S. LLC | 8 | $135 |
| Esperion Therapeutics, Inc. | 8 | $135 |
| Dexcom, Inc. | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Myriad Genetic Laboratories, Inc. | 4 | $86 |
| Procept Biorobotics Corporation | 1 | $84 |
| Novartis | 5 | $77 |
| Paratek Pharmaceuticals, Inc. | 3 | $72 |
| Axonics, Inc. | 3 | $70 |
| Abbott | 4 | $59 |
| Endo Pharmaceuticals Inc. | 2 | $50 |
| Antares Pharma, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $36 |
| Nevro Corp. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $26 |
| Boston Scientific | 1 | $23 |
| Photocure Inc | 1 | $21 |
| 180 Medical, Inc. | 1 | $19 |
| Medtronic | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Urovant Sciences Inc | 1 | $15 |
| Si-bone, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,565 in reported general payments places this provider in the 85th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $34,210 |
| JardianceEmpagliflozin | 22 | $30,386 |
| OzempicSemaglutide | 15 | $19,758 |
| MounjaroTirzepatide | 12 | $12,258 |
| Duloxetine Hcl | 38 | $1,629 |
| Atorvastatin Calcium | 134 | $1,564 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,077 |
| Lisinopril | 105 | $800 |
| Rosuvastatin Calcium | 31 | $729 |
| Levothyroxine Sodium | 84 | $689 |
| Fluticasone Propionate | 46 | $681 |
| Amlodipine Besylate | 73 | $653 |
| Montelukast Sodium | 34 | $648 |
| Potassium Chloride | 34 | $614 |
| Omeprazole | 28 | $559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $138 | $34,21026 claims |
| Boehringer IngelheimJardiance | $178 | $30,38622 claims |
| Novo NordiskOzempic | $572 | $19,75815 claims |
| Lilly USA, LLCMounjaro | $317 | $12,25812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,031 medical providers in Florida.
Other medical in Winter Haven
- Erin DouceyWinter Haven$202K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.